Table of Contents Author Guidelines Submit a Manuscript
Oxidative Medicine and Cellular Longevity
Volume 2018, Article ID 1346958, 15 pages
https://doi.org/10.1155/2018/1346958
Research Article

Resveratrol Inhibits ROS-Promoted Activation and Glycolysis of Pancreatic Stellate Cells via Suppression of miR-21

1Department of Hepatobiliary Surgery, First Affiliated Hospital of Xi’an Jiaotong University, Xi’an 710061, China
2Department of General Surgery, Second Affiliated Hospital of Xi’an Jiaotong University, Xi’an 710004, China
3Department of Anesthesiology, First Affiliated Hospital of Xi’an Jiaotong University, Xi’an 710061, China

Correspondence should be addressed to Qingyong Ma; nc.ude.utjx.liam@65amyq and Jiguang Ma; nc.ude.utjx@68amgj

Received 23 November 2017; Revised 28 January 2018; Accepted 15 February 2018; Published 26 April 2018

Academic Editor: Mithun Sinha

Copyright © 2018 Bin Yan et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. L. Siegel, K. D. Miller, and A. Jemal, “Cancer statistics, 2017,” CA: A Cancer Journal for Clinicians, vol. 67, no. 1, pp. 7–30, 2017. View at Publisher · View at Google Scholar · View at Scopus
  2. L. Rahib, B. D. Smith, R. Aizenberg, A. B. Rosenzweig, J. M. Fleshman, and L. M. Matrisian, “Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States,” Cancer Research, vol. 74, no. 11, pp. 2913–2921, 2014. View at Publisher · View at Google Scholar · View at Scopus
  3. D. von Ahrens, T. D. Bhagat, D. Nagrath, A. Maitra, and A. Verma, “The role of stromal cancer-associated fibroblasts in pancreatic cancer,” Journal of Hematology & Oncology, vol. 10, no. 1, p. 76, 2017. View at Publisher · View at Google Scholar · View at Scopus
  4. M. F. B. Nielsen, M. B. Mortensen, and S. Detlefsen, “Key players in pancreatic cancer-stroma interaction: cancer-associated fibroblasts, endothelial and inflammatory cells,” World Journal of Gastroenterology, vol. 22, no. 9, pp. 2678–2700, 2016. View at Publisher · View at Google Scholar · View at Scopus
  5. J. Haqq, L. M. Howells, G. Garcea, M. S. Metcalfe, W. P. Steward, and A. R. Dennison, “Pancreatic stellate cells and pancreas cancer: current perspectives and future strategies,” European Journal of Cancer, vol. 50, no. 15, pp. 2570–2582, 2014. View at Publisher · View at Google Scholar · View at Scopus
  6. A. Masamune, T. Watanabe, K. Kikuta, and T. Shimosegawa, “Roles of pancreatic stellate cells in pancreatic inflammation and fibrosis,” Clinical Gastroenterology and Hepatology, vol. 7, Supplement 11, pp. S48–S54, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. D. Tang, D. Wang, Z. Yuan et al., “Persistent activation of pancreatic stellate cells creates a microenvironment favorable for the malignant behavior of pancreatic ductal adenocarcinoma,” International Journal of Cancer, vol. 132, no. 5, pp. 993–1003, 2013. View at Publisher · View at Google Scholar · View at Scopus
  8. U. E. Martinez-Outschoorn, Z. Lin, C. Trimmer et al., “Cancer cells metabolically “fertilize” the tumor microenvironment with hydrogen peroxide, driving the Warburg effect: Implications for PET imaging of human tumors,” Cell Cycle, vol. 10, no. 15, pp. 2504–2520, 2011. View at Publisher · View at Google Scholar · View at Scopus
  9. J. Lei, X. Huo, W. Duan et al., “α-Mangostin inhibits hypoxia-driven ROS-induced PSC activation and pancreatic cancer cell invasion,” Cancer Letters, vol. 347, no. 1, pp. 129–138, 2014. View at Publisher · View at Google Scholar · View at Scopus
  10. A. Y. Wehr, E. E. Furth, V. Sangar, I. A. Blair, and K. H. Yu, “Analysis of the human pancreatic stellate cell secreted proteome,” Pancreas, vol. 40, no. 4, pp. 557–566, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. S. Pavlides, D. Whitaker-Menezes, R. Castello-Cros et al., “The reverse Warburg effect: aerobic glycolysis in cancer associated fibroblasts and the tumor stroma,” Cell Cycle, vol. 8, no. 23, pp. 3984–4001, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. S. Pavlides, I. Vera, R. Gandara et al., “Warburg meets autophagy: cancer-associated fibroblasts accelerate tumor growth and metastasis via oxidative stress, mitophagy, and aerobic glycolysis,” Antioxidants & Redox Signaling, vol. 16, no. 11, pp. 1264–1284, 2012. View at Publisher · View at Google Scholar · View at Scopus
  13. F. Sicard, M. Gayral, H. Lulka, L. Buscail, and P. Cordelier, “Targeting miR-21 for the therapy of pancreatic cancer,” Molecular Therapy, vol. 21, no. 5, pp. 986–994, 2013. View at Publisher · View at Google Scholar · View at Scopus
  14. O. Peralta-Zaragoza, J. Deas, A. Meneses-Acosta et al., “Relevance of miR-21 in regulation of tumor suppressor gene PTEN in human cervical cancer cells,” BMC Cancer, vol. 16, no. 1, p. 215, 2016. View at Publisher · View at Google Scholar · View at Scopus
  15. N. S. Wickramasinghe, T. T. Manavalan, S. M. Dougherty, K. A. Riggs, Y. Li, and C. M. Klinge, “Estradiol downregulates miR-21 expression and increases miR-21 target gene expression in MCF-7 breast cancer cells,” Nucleic Acids Research, vol. 37, no. 8, pp. 2584–2595, 2009. View at Publisher · View at Google Scholar · View at Scopus
  16. B. E. Kadera, L. Li, P. A. Toste et al., “MicroRNA-21 in pancreatic ductal adenocarcinoma tumor-associated fibroblasts promotes metastasis,” PLoS One, vol. 8, no. 8, article e71978, 2013. View at Publisher · View at Google Scholar · View at Scopus
  17. H. Uozaki, S. Morita, A. Kumagai et al., “Stromal miR-21 is more important than miR-21 of tumour cells for the progression of gastric cancer,” Histopathology, vol. 65, no. 6, pp. 775–783, 2014. View at Publisher · View at Google Scholar · View at Scopus
  18. A. K. Mitra, M. Zillhardt, Y. Hua et al., “MicroRNAs reprogram normal fibroblasts into cancer-associated fibroblasts in ovarian cancer,” Cancer Discovery, vol. 2, no. 12, pp. 1100–1108, 2012. View at Publisher · View at Google Scholar · View at Scopus
  19. J. K. Park, E. J. Lee, C. Esau, and T. D. Schmittgen, “Antisense inhibition of microRNA-21 or -221 arrests cell cycle, induces apoptosis, and sensitizes the effects of gemcitabine in pancreatic adenocarcinoma,” Pancreas, vol. 38, no. 7, pp. e190–e199, 2009. View at Publisher · View at Google Scholar · View at Scopus
  20. X. Yang, Y. Cheng, P. Li et al., “A lentiviral sponge for miRNA-21 diminishes aerobic glycolysis in bladder cancer T24 cells via the PTEN/PI3K/AKT/mTOR axis,” Tumour Biology, vol. 36, no. 1, pp. 383–391, 2015. View at Publisher · View at Google Scholar · View at Scopus
  21. J. Jagdeo, L. Adams, H. Lev-Tov, J. Sieminska, J. Michl, and N. Brody, “Dose-dependent antioxidant function of resveratrol demonstrated via modulation of reactive oxygen species in normal human skin fibroblasts in vitro,” Journal of Drugs in Dermatology, vol. 9, no. 12, pp. 1523–1526, 2010. View at Google Scholar
  22. M. Savi, L. Bocchi, R. Sala et al., “Parenchymal and stromal cells contribute to pro-inflammatory myocardial environment at early stages of diabetes: protective role of resveratrol,” Nutrients, vol. 8, no. 11, p. 729, 2016. View at Publisher · View at Google Scholar · View at Scopus
  23. V. Vendrely, E. Peuchant, E. Buscail et al., “Resveratrol and capsaicin used together as food complements reduce tumor growth and rescue full efficiency of low dose gemcitabine in a pancreatic cancer model,” Cancer Letters, vol. 390, pp. 91–102, 2017. View at Publisher · View at Google Scholar · View at Scopus
  24. F. Karimi Dermani, M. Saidijam, R. Amini, A. Mahdavinezhad, K. Heydari, and R. Najafi, “Resveratrol inhibits proliferation, invasion, and epithelial–mesenchymal transition by increasing miR-200c expression in HCT-116 colorectal cancer cells,” Journal of Cellular Biochemistry, vol. 118, no. 6, pp. 1547–1555, 2017. View at Publisher · View at Google Scholar · View at Scopus
  25. Z. Jiang, X. Chen, K. Chen et al., “YAP inhibition by resveratrol via activation of AMPK enhances the sensitivity of pancreatic cancer cells to gemcitabine,” Nutrients, vol. 8, no. 10, 2016. View at Publisher · View at Google Scholar · View at Scopus
  26. S. K. Roy, Q. Chen, J. Fu, S. Shankar, and R. K. Srivastava, “Resveratrol inhibits growth of orthotopic pancreatic tumors through activation of FOXO transcription factors,” PLoS One, vol. 6, no. 9, article e25166, 2011. View at Publisher · View at Google Scholar · View at Scopus
  27. A. Rauf, M. Imran, H. A. R. Suleria, B. Ahmad, D. G. Peters, and M. S. Mubarak, “A comprehensive review of the health perspectives of resveratrol,” Food & Function, vol. 8, no. 12, pp. 4284–4305, 2017. View at Publisher · View at Google Scholar
  28. A. Kumar, A. M. Rimando, and A. S. Levenson, “Resveratrol and pterostilbene as a microRNA-mediated chemopreventive and therapeutic strategy in prostate cancer,” Annals of the New York Academy of Sciences, vol. 1403, no. 1, pp. 15–26, 2017. View at Publisher · View at Google Scholar · View at Scopus
  29. W. Li, X. Ma, N. Li et al., “Resveratrol inhibits hexokinases II mediated glycolysis in non-small cell lung cancer via targeting Akt signaling pathway,” Experimental Cell Research, vol. 349, no. 2, pp. 320–327, 2016. View at Publisher · View at Google Scholar · View at Scopus
  30. L. S. Gomez, P. Zancan, M. C. Marcondes et al., “Resveratrol decreases breast cancer cell viability and glucose metabolism by inhibiting 6-phosphofructo-1-kinase,” Biochimie, vol. 95, no. 6, pp. 1336–1343, 2013. View at Publisher · View at Google Scholar · View at Scopus
  31. Z. Gao, X. Wang, K. Wu, Y. Zhao, and G. Hu, “Pancreatic stellate cells increase the invasion of human pancreatic cancer cells through the stromal cell-derived Factor-1/CXCR4 axis,” Pancreatology, vol. 10, no. 2-3, pp. 186–193, 2010. View at Publisher · View at Google Scholar · View at Scopus
  32. D. Whitaker-Menezes, U. E. Martinez-Outschoorn, Z. Lin et al., “Evidence for a stromal-epithelial “lactate shuttle” in human tumors: MCT4 is a marker of oxidative stress in cancer-associated fibroblasts,” Cell Cycle, vol. 10, no. 11, pp. 1772–1783, 2011. View at Publisher · View at Google Scholar · View at Scopus
  33. Y. Cheng, X. Liu, S. Zhang, Y. Lin, J. Yang, and C. Zhang, “MicroRNA-21 protects against the H(2)O(2)-induced injury on cardiac myocytes via its target gene PDCD4,” Journal of Molecular and Cellular Cardiology, vol. 47, no. 1, pp. 5–14, 2009. View at Publisher · View at Google Scholar · View at Scopus
  34. S. Sheth, S. Jajoo, T. Kaur et al., “Resveratrol reduces prostate cancer growth and metastasis by inhibiting the Akt/MicroRNA-21 pathway,” PLoS One, vol. 7, no. 12, article e51655, 2012. View at Publisher · View at Google Scholar · View at Scopus
  35. P. Liu, H. Liang, Q. Xia et al., “Resveratrol induces apoptosis of pancreatic cancers cells by inhibiting miR-21 regulation of BCL-2 expression,” Clinical & Translational Oncology, vol. 15, no. 9, pp. 741–746, 2013. View at Publisher · View at Google Scholar · View at Scopus
  36. G. Wang, F. Dai, K. Yu et al., “Resveratrol inhibits glioma cell growth via targeting oncogenic microRNAs and multiple signaling pathways,” International Journal of Oncology, vol. 46, no. 4, pp. 1739–1747, 2015. View at Publisher · View at Google Scholar · View at Scopus
  37. H. Oettle, S. Post, P. Neuhaus et al., “Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer: a randomized controlled trial,” JAMA, vol. 297, no. 3, pp. 267–277, 2007. View at Publisher · View at Google Scholar · View at Scopus
  38. J.-c. Lee, J. W. Kim, S. Ahn et al., “Optimal dose reduction of FOLFIRINOX for preserving tumour response in advanced pancreatic cancer: using cumulative relative dose intensity,” European Journal of Cancer, vol. 76, pp. 125–133, 2017. View at Publisher · View at Google Scholar · View at Scopus
  39. C. Baldini, A. Escande, O. Bouché et al., “Safety and efficacy of FOLFIRINOX in elderly patients with metastatic or locally advanced pancreatic adenocarcinoma: a retrospective analysis,” Pancreatology, vol. 17, no. 1, pp. 146–149, 2017. View at Publisher · View at Google Scholar · View at Scopus
  40. W. Mo, X. Xu, L. Xu et al., “Resveratrol inhibits proliferation and induces apoptosis through the hedgehog signaling pathway in pancreatic cancer cell,” Pancreatology, vol. 11, no. 6, pp. 601–609, 2011. View at Publisher · View at Google Scholar · View at Scopus
  41. W. Li, L. Cao, X. Chen, J. Lei, and Q. Ma, “Resveratrol inhibits hypoxia-driven ROS-induced invasive and migratory ability of pancreatic cancer cells via suppression of the Hedgehog signaling pathway,” Oncology Reports, vol. 35, no. 3, pp. 1718–1726, 2016. View at Publisher · View at Google Scholar · View at Scopus
  42. W. Li, J. Ma, Q. Ma et al., “Resveratrol inhibits the epithelial-mesenchymal transition of pancreatic cancer cells via suppression of the PI-3K/Akt/NF-κB Pathway,” Current Medicinal Chemistry, vol. 20, no. 33, pp. 4185–4194, 2013. View at Publisher · View at Google Scholar · View at Scopus
  43. P. Mukhopadhyay, S. Mukherjee, K. Ahsan, A. Bagchi, P. Pacher, and D. K. Das, “Restoration of altered microRNA expression in the ischemic heart with resveratrol,” PLoS One, vol. 5, no. 12, article e15705, 2010. View at Publisher · View at Google Scholar · View at Scopus
  44. R. Venkatadri, T. Muni, A. K. V. Iyer, J. S. Yakisich, and N. Azad, “Role of apoptosis-related miRNAs in resveratrol-induced breast cancer cell death,” Cell Death & Disease, vol. 7, no. 2, article e2104, 2016. View at Publisher · View at Google Scholar · View at Scopus
  45. S. Dhar, C. Hicks, and A. S. Levenson, “Resveratrol and prostate cancer: promising role for microRNAs,” Molecular Nutrition & Food Research, vol. 55, no. 8, pp. 1219–1229, 2011. View at Publisher · View at Google Scholar · View at Scopus
  46. R. Kadaba, H. Birke, J. Wang et al., “Imbalance of desmoplastic stromal cell numbers drives aggressive cancer processes,” The Journal of Pathology, vol. 230, no. 1, pp. 107–117, 2013. View at Publisher · View at Google Scholar · View at Scopus
  47. G. R. Ryu, E. Lee, H. J. Chun et al., “Oxidative stress plays a role in high glucose-induced activation of pancreatic stellate cells,” Biochemical and Biophysical Research Communications, vol. 439, no. 2, pp. 258–263, 2013. View at Publisher · View at Google Scholar · View at Scopus
  48. K. Kikuta, A. Masamune, M. Satoh, N. Suzuki, K. Satoh, and T. Shimosegawa, “Hydrogen peroxide activates activator protein-1 and mitogen-activated protein kinases in pancreatic stellate cells,” Molecular and Cellular Biochemistry, vol. 291, no. 1-2, pp. 11–20, 2006. View at Publisher · View at Google Scholar · View at Scopus
  49. S. W. Tsang, H. Zhang, Z. Lin, H. Mu, and Z. X. Bian, “Anti-fibrotic effect of trans-resveratrol on pancreatic stellate cells,” Biomedicine & Pharmacotherapy, vol. 71, pp. 91–97, 2015. View at Publisher · View at Google Scholar · View at Scopus
  50. P. A. Phillips, M. J. Wu, R. K. Kumar et al., “Cell migration: a novel aspect of pancreatic stellate cell biology,” Gut, vol. 52, no. 5, pp. 677–682, 2003. View at Publisher · View at Google Scholar · View at Scopus
  51. C. Capparelli, C. Guido, D. Whitaker-Menezes et al., “Autophagy and senescence in cancer-associated fibroblasts metabolically supports tumor growth and metastasis, via glycolysis and ketone production,” Cell Cycle, vol. 11, no. 12, pp. 2285–2302, 2012. View at Publisher · View at Google Scholar · View at Scopus
  52. A. Charrier, R. Chen, L. Chen et al., “Connective tissue growth factor (CCN2) and microRNA-21 are components of a positive feedback loop in pancreatic stellate cells (PSC) during chronic pancreatitis and are exported in PSC-derived exosomes,” Journal of Cell Communication and Signaling, vol. 8, no. 2, pp. 147–156, 2014. View at Publisher · View at Google Scholar · View at Scopus
  53. S. Ali, R. Suresh, S. Banerjee et al., “Contribution of microRNAs in understanding the pancreatic tumor microenvironment involving cancer associated stellate and fibroblast cells,” American Journal of Cancer Research, vol. 5, no. 3, pp. 1251–1264, 2015. View at Google Scholar
  54. S. Jiang, R. Wang, H. Yan, L. Jin, X. Dou, and D. Chen, “MicroRNA-21 modulates radiation resistance through upregulation of hypoxia-inducible factor-1α-promoted glycolysis in non-small cell lung cancer cells,” Molecular Medicine Reports, vol. 13, no. 5, pp. 4101–4107, 2016. View at Publisher · View at Google Scholar · View at Scopus
  55. R. B. Robey and N. Hay, “Is Akt the “Warburg kinase”?—Akt-energy metabolism interactions and oncogenesis,” Seminars in Cancer Biology, vol. 19, no. 1, pp. 25–31, 2009. View at Publisher · View at Google Scholar · View at Scopus
  56. X. Zha, Q. Sun, and H. Zhang, “mTOR upregulation of glycolytic enzymes promotes tumor development,” Cell Cycle, vol. 10, no. 7, pp. 1015-1016, 2011. View at Publisher · View at Google Scholar · View at Scopus
  57. T. Fiaschi, A. Marini, E. Giannoni et al., “Reciprocal metabolic reprogramming through lactate shuttle coordinately influences tumor-stroma interplay,” Cancer Research, vol. 72, no. 19, pp. 5130–5140, 2012. View at Publisher · View at Google Scholar · View at Scopus